Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park, Robert Huddart, Earle F. Burgess, Mustafa Özgüroğlu, Begoña P. Valderrama, Brigitte Laguerre, Umberto Basso, Spyros Triantos, Sydney Akapame, Yin Kean, Kris Deprince, S. Mukhopadhyay, Yohann Loriot, Patricia Bastick, Sanjeev Sewak, Ben Tran, Martin Pichler, Shahrokh F. Shariat, Sylvie Rottey, Peter Schatteman, Dirk Schrijvers, Vincent Verschaeve, Christof Vulsteke, Luiza Aleixo Barros Leite Ferreira, Pereira de Santana Gomes Andrea Juliana, João P. M. António, Sérgio Jobim Azevedo, Diogo Bastos, Giuliano Santos Borges, Aldo Lourenço Abbade Dettino, Pires Luis Antonio, Murilo Luz, Suelen Bianca Stopa Martins, José Maurício Mota, J M Octavio de Toledo, Bernhard J. Eigl, Daygen L. Finch, Joel Gingerich, Haiying Dong, Jian Huang, Jie Jin, Hongming Pan, Zhongquan Sun, Ye Tian, Ben Wan, Bin Wu, Ting Xu, Wei Xue, Fangjian Zhou, Philippe Barthélémy, Delphine Borchiellini, Fabien Calcagno, Aurélien Carnot, Pierre Cornillon, R. Delva, Sheik Emambux, Nadine Houédé, Brigitte Laguerre, Géraldine Lauridant, Yohann Loriot, Hakim Mahammedi, Denis Maillet, Damien Pouessel, Guilhem Roubaud, Friederike Schlürmann-Constans, Diégo Tosi, Sylvie Zanetta, Séverine Banek, Susan Feyerabend, Mario W. Kramer, Guenther Niegisch, Philipp Nuhn, Marco J. Schnabel, Christian Wuelfing, Sofia Baka, Aristotelis Bamias, George Fountzilas, Harabolos Kalofonos, Konstantinos Karalis, Αthanasios Kotsakis, Eleni Timotheadou, László Landherr, László Mangel, Avivit Peer, Meital Levratovsky, Umberto Basso, Nicola Battelli, Alessia Cavo, Ugo De Giorgi, Laura Doni, Luca Galli, Maria Olga Giganti, Valentina Guadalupi, Michele Maio, Laura Milesi, Franco Nolè, Giorgio V. Scagliotti, Giampaolo Tortora